Try our beta test site
33 studies found for:    "dengue" | Open Studies | Studies updated in the last 365 days
Show Display Options
Rank Status Study
1 Recruiting Assessment of a Dengue-1-Virus-Live Virus Human Challenge - (DENV-1-LVHC) Virus Strain
Condition: Dengue
Intervention: Biological: Dengue-1 Virus-Live Virus Human Challenge (DENV-1-LVHC)
2 Recruiting Immunogenicity and Safety of a Tetravalent Dengue Vaccine Booster Injection in Subjects Who Previously Completed a 3-dose Schedule
Conditions: Dengue Fever;   Dengue Hemorrhagic Fever
Interventions: Biological: CYD Dengue Vaccine (5 dose formulation);   Biological: Placebo, NaCl 0.9%
3 Recruiting TDENV PIV and LAV Dengue Prime-boost Strategy
Condition: Dengue
Interventions: Biological: TDENV-LAV;   Biological: TDENV-PIV 4 µg + alum adjuvant
4 Not yet recruiting Safety and Immunogenicity of a Tetravalent Dengue Vaccine in HIV-Positive Adults
Conditions: Dengue Fever;   Dengue Hemorrhagic Fever;   Human Immunodeficiency Virus
Interventions: Biological: CYD Dengue Vaccine;   Biological: Placebo (NaCl 0.9%) vaccine group
5 Recruiting Phase III Trial to Evaluate Efficacy and Safety of a Tetravalent Dengue Vaccine
Condition: Dengue
Interventions: Biological: Dengue 1,2,3,4 (attenuated) vaccine;   Other: Placebo
6 Not yet recruiting Cluster Randomized Trial of Wolbachia Against Dengue
Conditions: Dengue;   Zika Virus Infection;   Chikungunya Fever
Interventions: Biological: Wolbachia-infected Aedes aegypti mosquitoes;   Other: standard practice dengue control
7 Not yet recruiting Study of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Adacel® in Healthy Subjects
Conditions: Dengue Fever;   Dengue Hemorrhagic Fever
Interventions: Biological: CYD Dengue Vaccine;   Biological: Tdap: Tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed
8 Recruiting A Cohort Study to Determine the Incidence of Dengue Fever and to Build Capacity for Dengue Vaccine Trials in Dengue-endemic Regions of South Asia
Condition: Dengue
Intervention: Procedure: Blood sample collection
9 Recruiting An Epidemiological Surveillance Study to Evaluate the Incidence of Dengue in Brazil
Condition: Dengue
Interventions: Procedure: Blood sample collection;   Other: Data collection
10 Not yet recruiting Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Gardasil®
Conditions: Dengue Fever;   Dengue Hemorrhagic Fever;   Human Papillomavirus Disease
Interventions: Biological: CYD Dengue Vaccine;   Biological: Human Papillomavirus Quadrivalent [Types 6, 11, 16, and 18] Vaccine, Recombinant.
11 Recruiting Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Cervarix®
Conditions: Dengue Fever;   Dengue Hemorrhagic Fever;   Human Papillomavirus Disease
Interventions: Biological: CYD Dengue Vaccine;   Biological: Human Papillomavirus Bivalent [Types16 and 18] Vaccine, Recombinant.;   Biological: Human Papillomavirus Bivalent [Types 16 and 18] Vaccine, Recombinant.
12 Recruiting Diagnosing Dengue: Evaluating the Utility of Oral Fluid for Dengue Diagnosis
Condition: Dengue
Intervention: Device: SaniSal Oral Fluid Collector
13 Recruiting Safety and Immunogenicity of the Dengue Virus Vaccine TV005 (TetraVax-DV TV005) in Healthy Adults, Adolescents, and Children in Dhaka, Bangladesh
Condition: Dengue
Interventions: Biological: TV005 vaccine;   Biological: Placebo
14 Recruiting This Study Will Describe the Burden of DENgue Fever Virus (DENV) Illness Among Household Members Aged 6 Months to 50 Years of Selected Communities in Latin America and Southeast Asia
Condition: Dengue
Intervention: Procedure: Blood sample collection
15 Recruiting Evaluating the Safety and Immunogenicity of a Tetravalent Dengue Vaccine (TetraVax-DV) TV005 in Flavivirus-Naive Adults 50 to 70 Years of Age
Condition: Dengue
Interventions: Biological: TetraVax-DV TV005;   Biological: Placebo
16 Recruiting Evaluating the Safety and Protective Efficacy of a Single Dose of the Live Attenuated Tetravalent Dengue Vaccine TV005 to Protect Against Infection With rDEN3Δ30
Condition: Dengue
Interventions: Biological: TetraVax-DV-TV005;   Biological: rDEN3Δ30;   Biological: Placebo
17 Recruiting Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children
Condition: Healthy Volunteers
Interventions: Biological: Takeda's Tetravalent Dengue Vaccine Candidate;   Drug: TDV Placebo
18 Recruiting Investigation of the Immuno-regulation and Viral Hepatitis Among Patients With or After Dengue Fever Infection
Condition: Dengue Fever
Intervention: Other: case/control
19 Recruiting The Use of Biomarkers in Predicting Dengue Outcome
Condition: Dengue
Intervention:
20 Not yet recruiting Safety and Immunogenicity of Takeda's TDV in Healthy Children
Condition: Healthy Volunteers
Intervention: Biological: Tetravalent Dengue Vaccine Candidate

   Previous Page Studies Shown (1-20) Next Page (21-33) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.